MAZE logo

Maze Therapeutics, Inc. (MAZE) Selling, general & administrative expenses

annual SGA:

$26.42M+$1.81M(+7.36%)
December 31, 2024

Summary

  • As of today (September 16, 2025), MAZE annual SGA is $26.42 million, with the most recent change of +$1.81 million (+7.36%) on December 31, 2024.
  • During the last 3 years, MAZE annual SGA has risen by +$3.58 million (+15.70%).
  • MAZE annual SGA is now at all-time high.

Performance

MAZE SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

quarterly SGA:

$0.00-$7.82M(-100.00%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MAZE quarterly SGA is $0.00, with the most recent change of -$7.82 million (-100.00%) on June 30, 2025.
  • Over the past year, MAZE quarterly SGA has dropped by -$5.90 million (-100.00%).
  • MAZE quarterly SGA is now -100.00% below its all-time high of $7.82 million, reached on March 31, 2025.

Performance

MAZE quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

TTM SGA:

-$1.49B-$135.77M(-10.04%)
June 30, 2025

Summary

  • As of today (September 16, 2025), MAZE TTM SGA is -$1.49 billion, with the most recent change of -$135.77 million (-10.04%) on June 30, 2025.
  • Over the past year, MAZE TTM SGA has dropped by -$1.49 billion (-25331.53%).
  • MAZE TTM SGA is now -276.16% below its all-time high of -$395.69 million.

Performance

MAZE TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMAZEincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

MAZE Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.4%-100.0%-10000.0%
3 y3 years+15.7%0.0%-100.0%
5 y5 years+15.7%0.0%-100.0%

MAZE Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+15.7%-100.0%at low-276.2%at low
5 y5-yearat high+15.7%-100.0%at low-276.2%at low
alltimeall timeat high+15.7%-100.0%at low-276.2%at low

MAZE Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$7.82M(-43.0%)
Mar 2025
-
$7.82M(>+9900.0%)
$13.72M(+132.6%)
Dec 2024
$26.42M
$0.00(0.0%)
$5.90M(0.0%)
Sep 2024
-
$0.00(-100.0%)
$5.90M(0.0%)
DateAnnualQuarterlyTTM
Jun 2024
-
$5.90M(>+9900.0%)
$5.90M(>+9900.0%)
Mar 2024
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2023
$24.61M(+7.8%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2023
-
$0.00
$0.00
Dec 2022
$22.83M
-
-

FAQ

  • What is Maze Therapeutics, Inc. annual SGA?
  • What is the all time high annual SGA for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. annual SGA year-on-year change?
  • What is Maze Therapeutics, Inc. quarterly SGA?
  • What is the all time high quarterly SGA for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. quarterly SGA year-on-year change?
  • What is Maze Therapeutics, Inc. TTM SGA?
  • What is the all time high TTM SGA for Maze Therapeutics, Inc.?
  • What is Maze Therapeutics, Inc. TTM SGA year-on-year change?

What is Maze Therapeutics, Inc. annual SGA?

The current annual SGA of MAZE is $26.42M

What is the all time high annual SGA for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high annual SGA is $26.42M

What is Maze Therapeutics, Inc. annual SGA year-on-year change?

Over the past year, MAZE annual SGA has changed by +$1.81M (+7.36%)

What is Maze Therapeutics, Inc. quarterly SGA?

The current quarterly SGA of MAZE is $0.00

What is the all time high quarterly SGA for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high quarterly SGA is $7.82M

What is Maze Therapeutics, Inc. quarterly SGA year-on-year change?

Over the past year, MAZE quarterly SGA has changed by -$5.90M (-100.00%)

What is Maze Therapeutics, Inc. TTM SGA?

The current TTM SGA of MAZE is -$1.49B

What is the all time high TTM SGA for Maze Therapeutics, Inc.?

Maze Therapeutics, Inc. all-time high TTM SGA is -$395.69M

What is Maze Therapeutics, Inc. TTM SGA year-on-year change?

Over the past year, MAZE TTM SGA has changed by -$1.49B (-25331.53%)
On this page